ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Omeros’ investigational new drug application for OMS906 cleared by FDA
September 03, 2020Omeros Corporation today announced that its Investigational New Drug Application (IND) to begin clinical trials with OMS906 has been cleared by the U.S. Food and Drug Administration (FDA). -
Omeros reports positive results for Narsoplimab in treatment of Covid-19-associated ARDS
August 13, 2020Omeros Corporation reported the results of a compassionate-use study evaluating narsoplimab, Omeros’ investigational human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2) ... -
Omeros, Lonza Enter Commercial Manufacturing Agreement
August 01, 2019Builds on existing clinical supply deal for narsoplimab. -
Omeros Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy
January 21, 2019Omeros has finalized its clinical plan for OMS721 submission and approval in immunoglobulin A nephropathy (IgAN) following a recent meeting with the U.S. Food and Drug Administration (FDA)..... -
Omeros defends drug data, vows to unmask short seller
August 25, 2017Omeros put out the statement to fend off attacks on two fronts.
Pharma Sources Insight January 2025
